Day: July 10, 2023

Company Continues to Implement Major Change in Strategy Focused on Acquiring and Operating Accretive Revenue Generating Laboratories and Related Commercialized Products Company Plans on Developing and Delivering Innovative, Transformative, Precision Diagnostics, Genetic Testing and Clinical Laboratory Services FREEHOLD, N.J., July 10, 2023 (GLOBE NEWSWIRE) — Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory services, today provided the following letter to shareholders from the Company’s President and CEO, David Jin, M.D., Ph.D.: “We are excited to provide an update on our new commercial strategy focused on laboratory acquisitions and diagnostics. Avalon is dedicated to developing and delivering innovative, transformative, precision...

KARTOON STUDIOS’ PREMIERE OF SHAQ’S GARAGE, STARRING SHAQUILLE O’NEAL, OUTPERFORMS DURING JUNE EXCLUSIVE ON PLUTO TV Series Delivers More Video On Demand Viewers Than All of Kartoon Channel!’s Other Series CombinedSeries Delivers More Video On Demand Viewers Than All of Kartoon Channel!’s Other Series Combined Increased Weekly Kartoon Channel! Viewers by 50% and Captured All Three Most Viewed Episode Spots Series Debuts Today Across All Kartoon Channel! Platforms, Including Amazon Prime Video, Roku, Apple, Google, Android & MoreBEVERLY HILLS, Calif., July 10, 2023 (GLOBE NEWSWIRE) — Kartoon Studios, (NYSE American: TOON) announced today the broad debut of “Shaq’s Garage,” starring and executive produced by the legendary Shaquille O’Neal, across Kartoon Channel! platforms, following its successful exclusive premiere...

ATLANTA, GA, July 10, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced today the presentation of Phase 1/2 clinical trial data for GeoVax’s gene therapy candidate, Gedeptin® at the American Association for Cancer Research (AACR) and the American Head and Neck Society (AHNS) joint Head and Neck Cancer Conference in Montréal, QC, Canada. The presentation, titled “Phase 1/ 2 study of Ad/PNP with fludarabine for the treatment of head neck squamous cell carcinoma (HNSCC)”, describes the evaluation of Gedeptin as an experimental therapy for refractory solid tumors. Gedeptin is a novel patented product/technology for the treatment of solid tumors through a gene therapy strategy known as Gene-Directed...

Jupiter Wellness, Inc World’s First Rapid Blood Alcohol Detox Drink “Safety Shot”Asset valued at $53 million by a third party Valuation firm JUPITER, FL, July 10, 2023 (GLOBE NEWSWIRE) — Jupiter Wellness, Inc. (Nasdaq: JUPW), a diversified company that supports health and wellness, today announced it has executed an Asset Purchase Agreement with GBB Drink Lab Inc.. As per the Agreement, all operating assets related to GBB Drink Lab, including the revolutionary Safety Shot beverage, will belong to Jupiter Wellness, Safety Shot creates a new product category for rapid alcohol detoxification in the fast-growing hangover remedy market. Safety Shot is protected by a number of issued and pending patents covering composition of matter and methods of use. Created by a doctor and validated by research, Safety Shot helps your body break...

Oslo, 10 July 2023 – DNO ASA, the Norwegian oil and gas operator, today announced a significant gas and condensate discovery on the Carmen prospect in the Norwegian North Sea license PL1148 in which the Company holds a 30 percent interest. Preliminary evaluation of comprehensive data, including cores and fluid samples, acquired from the discovery well and a follow-on extended sidetrack indicates gross recoverable resources in the range of 120-230 million barrels of oil equivalent (MMboe) on a P90-P10 basis. At 175 MMboe, the mid-point of this range, Carmen ranks as the largest discovery on the Norwegian Continental Shelf since 2013. The two wells have established a deeper hydrocarbon-water contact, tripling the mid-point of DNO’s pre-drill expected range. Carmen is DNO’s sixth discovery in the Troll-Gjøa area since 2021 and is located close...

Lead bispecific antibody, HSB-3215 designed to target novel conformational epitopes on high value validated targets, HER2 and HER3 Focus on optimizing ADCs to generate a more potent Bystander Effect and proprietary novel bovine-derived biologic platform, PicoKnobTM, targeting undruggable epitopes on PD-1 and TROP2 Experienced biopharmaceutical executive joins as Chief Operating Officer to spearhead execution of ADC and biologic strategy BRIDGEWATER, N.J., July 10, 2023 (GLOBE NEWSWIRE) —  Hillstream BioPharma (Nasdaq: HILS) a biotechnology company developing innovative therapeutic candidates targeting drug resistant and devastating cancers that can make a difference in patients’ lives, today announced a strategic reprioritization of its pipeline and provided a corporate update. The strategic assessment took into account, the pipeline’s...

ATLANTA, July 10, 2023 (GLOBE NEWSWIRE) — Cumulus Media Inc. (NASDAQ: CMLS) will host a conference call on Friday, July 28th at 8:30 AM ET to discuss its second quarter 2023 operating results. A press release containing a summary of these results will be issued before the call at approximately 8:00 AM ET. To participate in the conference call, please register in advance using this link. NetRoadshow (NRS) is the service provider for this call. Registration requires a one-time only email address verification. Upon completing registration, a calendar invitation will follow with call access details, including a unique PIN, and replay details. The conference call will also be broadcast live in listen-only mode through a link on the Company’s investor relations website at www.cumulusmedia.com/investors. This link can also be used to...

Kaled Awada brings global leadership and human resources expertise Susan Kreh brings financial and information technology expertiseLOUISVILLE, Colo., July 10, 2023 (GLOBE NEWSWIRE) — Solid Power, Inc. (“Solid Power”) (Nasdaq: SLDP), a developer of solid state battery technology, today announced two new appointments to its board of directors: Kaled Awada, a C-level leader in global human resource management, and Susan Kreh, a C-level executive with more than 35 years of finance and information technology leadership. The two joined Solid Power’s board of directors effective July 5, 2023. “Kaled and Susan bring to Solid Power extensive leadership experience in their respective fields, and will provide valuable guidance as Solid Power continues to grow and execute on its strategy,” said Dave Jansen, Chairperson of Solid...

Enrollment progressing toward interim analysis planned when 36 subjects reach 12 weeks on treatment in Part 1 of study BOSTON and LONDON, July 10, 2023 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company focused on discovering and developing medicines that are transformational for patients, today announced the dosing of the first subject in its registrational PRESent-2 study of SerpinPC for the treatment of hemophilia B without inhibitors. The dosing phase of PRESent-2 follows a minimum 12-week observation period during which prospective baseline data of the subject’s disease status under their current therapy are collected to support regulatory review of the benefit and risk profile of SerpinPC. SerpinPC is an investigational subcutaneously administered novel inhibitor of activated...